Randomized trial of telmisartan and/or enalapril on renoprotective effects for patients of chronic renal diseases with hypertension.
Not Applicable
- Conditions
- Chronic Kidney Diseases
- Registration Number
- JPRN-C000000299
- Lead Sponsor
- Institute of Clinical Medicine, University of Tsukuba
- Brief Summary
Because there was little accumulation of the number of cases, this study was terminated.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with allergy for angiotensin converting enzyme-inhibitor or angiotensin receptor blocker, liver injury, or pregnancy. Patients who are inadequate to entry this study by physicians in charge.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effects of treatments with angiotensin converting enzyme-inhibitor &/or angiotensin receptor blocker on blood pressure, excretion of urinary protein, serum creatinine level and creatinine clearance.
- Secondary Outcome Measures
Name Time Method Adverse effects of angiotensin converting enzyme-inhibitor &/or angiotensin receptor blocker.